(Q44138224)

30 November 2017

title

Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720. (English)

1 reference

30 November 2017

0 references

1

1 reference

30 November 2017

M Hensmann

2

1 reference

30 November 2017

J Sattabongkot

3

1 reference

30 November 2017

W E Collins

4

1 reference

30 November 2017

J W Barnwell

5

1 reference

30 November 2017

J A M Langermans

6

1 reference

30 November 2017

Y Wu

7

1 reference

30 November 2017

C A Long

8

1 reference

30 November 2017

F Dubovsky

9

1 reference

30 November 2017

A W Thomas

10

1 reference

30 November 2017

publication date

1 October 2007

1 reference

30 November 2017

1 reference

30 November 2017

volume

29

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

525-533

1 reference

Malaria transmission-blocking vaccines--how can their development be supported?

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00971.X

10.1111/J.1365-3024.2007.00971.X

21 January 2018

Identifiers

DOI

1 reference

release_e7jeooe7wrbzrcbjogeyncg35a

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e7jeooe7wrbzrcbjogeyncg35a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference